Shift Bioscience
United Kingdom · $16.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- shiftbioscience.com
- Total Funding
- $16.0M
- Last Round
- $16.0M SeedOct 2024
- Rounds
- 1
About
Biotech company using cell biology and machine learning to reverse aging through cell rejuvenation therapies.
Summary
Shift Bioscience is a Biotech company based in United Kingdom. It has raised $16.0M in total across 1 round, most recently a $16.0M Seed round in Oct 2024. Investors include BGF, F-Prime Capital and Kindred Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company